United States
Print page content Print
Increase text size Decrease text size
Text Size

TORBUTROL® (butorphanol tartrate)

Helps to relieve chronic coughing in dogs

TORBUTROL is indicated for the relief of chronic non-productive cough associated with tracheobronchitis, tracheitis, tonsillitis, laryngitis and pharyngitis originating from inflammatory conditions of the upper respiratory tract.

  • The usual parenteral dose of TORBUTROL is 0.025 mg of butorphanol base activity per lb of body weight. This is the equivalent of 1/2 mL (0.5 mL) for each 10 lbs of body weight. It should be administered by subcutaneous injection, and repeated at intervals of 6 to 12 hours as required. If necessary, the dose may be increased to a maximum of 0.05 mg/lb or 1 mL/10 lbs body weight. Treatment should not normally be required for longer than seven days.
     

    The usual oral dose of TORBUTROL is 0.25 mg of butorphanol base activity per lb of body weight. This is the equivalent of one 5 mg tablet per 20 lbs of body weight. The dose should be repeated at intervals of 6 to 12 hours as required. If necessary, the dose may be increased to a maximum of one 5 mg tablet for each 10 lbs of body weight. Treatment should not normally be required for longer than seven days.


Important Safety Information: Use TORBUTROL in dogs only. Not recommended for use in pregnant dogs. The safety of TORBUTROL has not been determined in dogs afflicted with heartworm disease (Dirofilaria immitis).TORBUTROL should not be used in dogs with a history of liver disease. Since TORBUTROL can be effective in totally suppressing cough, it should not be used in conditions of the lower respiratory tract associated with copious mucus production. Use with caution with other sedative or analgesic drugs as these are likely to produce additive effects. In clinical trials, the most frequent adverse reaction reported was slight sedation.
For more safety information, refer to the full Prescribing Information.